nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP2C9—Disulfiram—alcohol dependence	0.237	0.501	CbGbCtD
Glipizide—CYP3A4—Disulfiram—alcohol dependence	0.138	0.291	CbGbCtD
Glipizide—CYP3A4—Citalopram—alcohol dependence	0.0981	0.208	CbGbCtD
Glipizide—Eruption—Disulfiram—alcohol dependence	0.012	0.0354	CcSEcCtD
Glipizide—Gastrointestinal tract irritation—Naltrexone—alcohol dependence	0.00967	0.0284	CcSEcCtD
Glipizide—ABCC8—Inwardly rectifying K+ channels—KCNJ6—alcohol dependence	0.00917	0.0817	CbGpPWpGaD
Glipizide—KCNJ11—Inwardly rectifying K+ channels—KCNJ6—alcohol dependence	0.00889	0.0792	CbGpPWpGaD
Glipizide—Alcohol intolerance—Citalopram—alcohol dependence	0.00688	0.0202	CcSEcCtD
Glipizide—Haematochezia—Citalopram—alcohol dependence	0.00543	0.016	CcSEcCtD
Glipizide—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.0051	0.0455	CbGpPWpGaD
Glipizide—Abdominal discomfort—Disulfiram—alcohol dependence	0.00446	0.0131	CcSEcCtD
Glipizide—Drowsiness—Disulfiram—alcohol dependence	0.00414	0.0122	CcSEcCtD
Glipizide—Jaundice—Disulfiram—alcohol dependence	0.00404	0.0119	CcSEcCtD
Glipizide—ABCC8—brainstem—alcohol dependence	0.00385	0.0512	CbGeAlD
Glipizide—Inappropriate antidiuretic hormone secretion—Citalopram—alcohol dependence	0.00376	0.0111	CcSEcCtD
Glipizide—Hepatitis—Disulfiram—alcohol dependence	0.00372	0.0109	CcSEcCtD
Glipizide—ABCC8—forebrain—alcohol dependence	0.00372	0.0494	CbGeAlD
Glipizide—Hypoaesthesia—Disulfiram—alcohol dependence	0.0037	0.0109	CcSEcCtD
Glipizide—ABCC8—Potassium Channels—KCNJ6—alcohol dependence	0.00362	0.0323	CbGpPWpGaD
Glipizide—KCNJ11—Potassium Channels—KCNJ6—alcohol dependence	0.00351	0.0313	CbGpPWpGaD
Glipizide—KCNJ11—cardiovascular system—alcohol dependence	0.00341	0.0453	CbGeAlD
Glipizide—Cramps of lower extremities—Acamprosate—alcohol dependence	0.00335	0.00986	CcSEcCtD
Glipizide—KCNJ11—pancreas—alcohol dependence	0.00332	0.0441	CbGeAlD
Glipizide—Urine output increased—Acamprosate—alcohol dependence	0.0033	0.00971	CcSEcCtD
Glipizide—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00327	0.0291	CbGpPWpGaD
Glipizide—Abnormal vision—Acamprosate—alcohol dependence	0.00318	0.00936	CcSEcCtD
Glipizide—ABCC8—cardiovascular system—alcohol dependence	0.00314	0.0417	CbGeAlD
Glipizide—ABCC8—pancreas—alcohol dependence	0.00306	0.0406	CbGeAlD
Glipizide—Polyuria—Acamprosate—alcohol dependence	0.00302	0.00888	CcSEcCtD
Glipizide—Eczema—Acamprosate—alcohol dependence	0.00295	0.00867	CcSEcCtD
Glipizide—Libido decreased—Acamprosate—alcohol dependence	0.00286	0.0084	CcSEcCtD
Glipizide—PPARG—forebrain—alcohol dependence	0.00284	0.0377	CbGeAlD
Glipizide—Thirst—Acamprosate—alcohol dependence	0.00278	0.00819	CcSEcCtD
Glipizide—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00271	0.0241	CbGpPWpGaD
Glipizide—Libido decreased—Naltrexone—alcohol dependence	0.0027	0.00795	CcSEcCtD
Glipizide—Hyponatraemia—Acamprosate—alcohol dependence	0.00266	0.00783	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.00265	0.00779	CcSEcCtD
Glipizide—Diplopia—Acamprosate—alcohol dependence	0.00265	0.00779	CcSEcCtD
Glipizide—Thirst—Naltrexone—alcohol dependence	0.00263	0.00775	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.00263	0.00773	CcSEcCtD
Glipizide—Migraine—Acamprosate—alcohol dependence	0.00261	0.00767	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.00251	0.00737	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.00249	0.00732	CcSEcCtD
Glipizide—Migraine—Naltrexone—alcohol dependence	0.00247	0.00726	CcSEcCtD
Glipizide—ABCC8—midbrain—alcohol dependence	0.00245	0.0326	CbGeAlD
Glipizide—PPARG—cardiovascular system—alcohol dependence	0.0024	0.0319	CbGeAlD
Glipizide—Paraesthesia—Disulfiram—alcohol dependence	0.00237	0.00698	CcSEcCtD
Glipizide—Somnolence—Disulfiram—alcohol dependence	0.00235	0.00691	CcSEcCtD
Glipizide—KCNJ11—endocrine gland—alcohol dependence	0.00234	0.0311	CbGeAlD
Glipizide—PPARG—pancreas—alcohol dependence	0.00233	0.031	CbGeAlD
Glipizide—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.0023	0.0205	CbGpPWpGaD
Glipizide—Abdominal pain upper—Naltrexone—alcohol dependence	0.00229	0.00673	CcSEcCtD
Glipizide—Pain—Disulfiram—alcohol dependence	0.00226	0.00665	CcSEcCtD
Glipizide—Gait disturbance—Citalopram—alcohol dependence	0.00224	0.00659	CcSEcCtD
Glipizide—KCNJ11—nervous system—alcohol dependence	0.00219	0.0291	CbGeAlD
Glipizide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00218	0.0194	CbGpPWpGaD
Glipizide—ABCC8—endocrine gland—alcohol dependence	0.00216	0.0286	CbGeAlD
Glipizide—KCNJ11—central nervous system—alcohol dependence	0.00211	0.028	CbGeAlD
Glipizide—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00209	0.00615	CcSEcCtD
Glipizide—Abdominal discomfort—Naltrexone—alcohol dependence	0.00208	0.00611	CcSEcCtD
Glipizide—KCNJ11—cerebellum—alcohol dependence	0.00206	0.0274	CbGeAlD
Glipizide—ABCC8—testis—alcohol dependence	0.00206	0.0273	CbGeAlD
Glipizide—Aplastic anaemia—Citalopram—alcohol dependence	0.00205	0.00604	CcSEcCtD
Glipizide—ABCC8—nervous system—alcohol dependence	0.00202	0.0268	CbGeAlD
Glipizide—Cramps of lower extremities—Citalopram—alcohol dependence	0.00201	0.00591	CcSEcCtD
Glipizide—PPARG—digestive system—alcohol dependence	0.00199	0.0265	CbGeAlD
Glipizide—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00198	0.0176	CbGpPWpGaD
Glipizide—Urine output increased—Citalopram—alcohol dependence	0.00198	0.00582	CcSEcCtD
Glipizide—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00196	0.0174	CbGpPWpGaD
Glipizide—Sweating—Acamprosate—alcohol dependence	0.00196	0.00576	CcSEcCtD
Glipizide—ABCC8—central nervous system—alcohol dependence	0.00194	0.0258	CbGeAlD
Glipizide—Hypertonia—Citalopram—alcohol dependence	0.00192	0.00564	CcSEcCtD
Glipizide—Abnormal vision—Citalopram—alcohol dependence	0.00191	0.00561	CcSEcCtD
Glipizide—ABCC8—cerebellum—alcohol dependence	0.0019	0.0252	CbGeAlD
Glipizide—PPARG—blood—alcohol dependence	0.0019	0.0252	CbGeAlD
Glipizide—Asthenia—Disulfiram—alcohol dependence	0.0019	0.00558	CcSEcCtD
Glipizide—Conjunctivitis—Naltrexone—alcohol dependence	0.00188	0.00552	CcSEcCtD
Glipizide—Rhinitis—Acamprosate—alcohol dependence	0.00184	0.00541	CcSEcCtD
Glipizide—Hepatitis—Acamprosate—alcohol dependence	0.00183	0.00539	CcSEcCtD
Glipizide—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00183	0.00537	CcSEcCtD
Glipizide—Hypoaesthesia—Acamprosate—alcohol dependence	0.00182	0.00536	CcSEcCtD
Glipizide—Pharyngitis—Acamprosate—alcohol dependence	0.00182	0.00535	CcSEcCtD
Glipizide—Polyuria—Citalopram—alcohol dependence	0.00181	0.00532	CcSEcCtD
Glipizide—Eczema—Citalopram—alcohol dependence	0.00177	0.0052	CcSEcCtD
Glipizide—Visual impairment—Acamprosate—alcohol dependence	0.00177	0.0052	CcSEcCtD
Glipizide—Haemolytic anaemia—Citalopram—alcohol dependence	0.00176	0.00518	CcSEcCtD
Glipizide—Dizziness—Disulfiram—alcohol dependence	0.00175	0.00514	CcSEcCtD
Glipizide—Hepatitis—Naltrexone—alcohol dependence	0.00173	0.0051	CcSEcCtD
Glipizide—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00172	0.0154	CbGpPWpGaD
Glipizide—Pharyngitis—Naltrexone—alcohol dependence	0.00172	0.00506	CcSEcCtD
Glipizide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00172	0.0153	CbGpPWpGaD
Glipizide—Libido decreased—Citalopram—alcohol dependence	0.00171	0.00504	CcSEcCtD
Glipizide—Visual disturbance—Citalopram—alcohol dependence	0.00168	0.00493	CcSEcCtD
Glipizide—KCNJ11—brain—alcohol dependence	0.00167	0.0222	CbGeAlD
Glipizide—Thirst—Citalopram—alcohol dependence	0.00167	0.00491	CcSEcCtD
Glipizide—Rash—Disulfiram—alcohol dependence	0.00167	0.0049	CcSEcCtD
Glipizide—Headache—Disulfiram—alcohol dependence	0.00166	0.00487	CcSEcCtD
Glipizide—PPARG—endocrine gland—alcohol dependence	0.00165	0.0219	CbGeAlD
Glipizide—Chills—Acamprosate—alcohol dependence	0.00164	0.00484	CcSEcCtD
Glipizide—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00164	0.0146	CbGpPWpGaD
Glipizide—Hypoglycaemia—Citalopram—alcohol dependence	0.00163	0.00479	CcSEcCtD
Glipizide—Eye disorder—Naltrexone—alcohol dependence	0.00162	0.00477	CcSEcCtD
Glipizide—Hyponatraemia—Citalopram—alcohol dependence	0.00159	0.00469	CcSEcCtD
Glipizide—Diplopia—Citalopram—alcohol dependence	0.00159	0.00467	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.00159	0.00467	CcSEcCtD
Glipizide—ABCC8—Neuronal System—KCNJ6—alcohol dependence	0.00158	0.0141	CbGpPWpGaD
Glipizide—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.00158	0.00464	CcSEcCtD
Glipizide—Flatulence—Acamprosate—alcohol dependence	0.00157	0.00463	CcSEcCtD
Glipizide—PPARG—testis—alcohol dependence	0.00157	0.0208	CbGeAlD
Glipizide—Tension—Acamprosate—alcohol dependence	0.00157	0.00461	CcSEcCtD
Glipizide—Migraine—Citalopram—alcohol dependence	0.00156	0.0046	CcSEcCtD
Glipizide—Chills—Naltrexone—alcohol dependence	0.00156	0.00458	CcSEcCtD
Glipizide—Nervousness—Acamprosate—alcohol dependence	0.00155	0.00456	CcSEcCtD
Glipizide—ABCC8—brain—alcohol dependence	0.00154	0.0205	CbGeAlD
Glipizide—PPARG—nervous system—alcohol dependence	0.00154	0.0205	CbGeAlD
Glipizide—Muscle spasms—Acamprosate—alcohol dependence	0.00153	0.00451	CcSEcCtD
Glipizide—KCNJ11—Neuronal System—KCNJ6—alcohol dependence	0.00153	0.0137	CbGpPWpGaD
Glipizide—Tremor—Acamprosate—alcohol dependence	0.00149	0.0044	CcSEcCtD
Glipizide—Flatulence—Naltrexone—alcohol dependence	0.00149	0.00438	CcSEcCtD
Glipizide—PPARG—liver—alcohol dependence	0.00148	0.0197	CbGeAlD
Glipizide—PPARG—central nervous system—alcohol dependence	0.00148	0.0197	CbGeAlD
Glipizide—Tension—Naltrexone—alcohol dependence	0.00148	0.00436	CcSEcCtD
Glipizide—Ill-defined disorder—Acamprosate—alcohol dependence	0.00148	0.00435	CcSEcCtD
Glipizide—Nervousness—Naltrexone—alcohol dependence	0.00147	0.00431	CcSEcCtD
Glipizide—Muscle spasms—Naltrexone—alcohol dependence	0.00145	0.00427	CcSEcCtD
Glipizide—Abdominal pain upper—Citalopram—alcohol dependence	0.00145	0.00427	CcSEcCtD
Glipizide—Malaise—Acamprosate—alcohol dependence	0.00144	0.00423	CcSEcCtD
Glipizide—Vertigo—Acamprosate—alcohol dependence	0.00143	0.00422	CcSEcCtD
Glipizide—Syncope—Acamprosate—alcohol dependence	0.00143	0.00421	CcSEcCtD
Glipizide—Leukopenia—Acamprosate—alcohol dependence	0.00143	0.0042	CcSEcCtD
Glipizide—Vision blurred—Naltrexone—alcohol dependence	0.00142	0.00419	CcSEcCtD
Glipizide—Tremor—Naltrexone—alcohol dependence	0.00141	0.00416	CcSEcCtD
Glipizide—CYP2C9—cardiovascular system—alcohol dependence	0.00141	0.0187	CbGeAlD
Glipizide—Loss of consciousness—Acamprosate—alcohol dependence	0.0014	0.00413	CcSEcCtD
Glipizide—Ill-defined disorder—Naltrexone—alcohol dependence	0.0014	0.00412	CcSEcCtD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.0014	0.0124	CbGpPWpGaD
Glipizide—Hypertension—Acamprosate—alcohol dependence	0.00138	0.00405	CcSEcCtD
Glipizide—Malaise—Naltrexone—alcohol dependence	0.00136	0.004	CcSEcCtD
Glipizide—Myalgia—Acamprosate—alcohol dependence	0.00136	0.004	CcSEcCtD
Glipizide—Arthralgia—Acamprosate—alcohol dependence	0.00136	0.004	CcSEcCtD
Glipizide—Syncope—Naltrexone—alcohol dependence	0.00135	0.00398	CcSEcCtD
Glipizide—Anxiety—Acamprosate—alcohol dependence	0.00135	0.00398	CcSEcCtD
Glipizide—Discomfort—Acamprosate—alcohol dependence	0.00134	0.00395	CcSEcCtD
Glipizide—Loss of consciousness—Naltrexone—alcohol dependence	0.00133	0.0039	CcSEcCtD
Glipizide—Abdominal discomfort—Citalopram—alcohol dependence	0.00132	0.00387	CcSEcCtD
Glipizide—Confusional state—Acamprosate—alcohol dependence	0.00131	0.00386	CcSEcCtD
Glipizide—Pancytopenia—Citalopram—alcohol dependence	0.0013	0.00383	CcSEcCtD
Glipizide—Hypertension—Naltrexone—alcohol dependence	0.0013	0.00383	CcSEcCtD
Glipizide—Myalgia—Naltrexone—alcohol dependence	0.00129	0.00378	CcSEcCtD
Glipizide—Arthralgia—Naltrexone—alcohol dependence	0.00129	0.00378	CcSEcCtD
Glipizide—Dysuria—Citalopram—alcohol dependence	0.00128	0.00378	CcSEcCtD
Glipizide—Shock—Acamprosate—alcohol dependence	0.00128	0.00377	CcSEcCtD
Glipizide—Anxiety—Naltrexone—alcohol dependence	0.00128	0.00377	CcSEcCtD
Glipizide—Thrombocytopenia—Acamprosate—alcohol dependence	0.00127	0.00375	CcSEcCtD
Glipizide—Discomfort—Naltrexone—alcohol dependence	0.00127	0.00374	CcSEcCtD
Glipizide—Hyperhidrosis—Acamprosate—alcohol dependence	0.00126	0.0037	CcSEcCtD
Glipizide—Photosensitivity reaction—Citalopram—alcohol dependence	0.00125	0.00369	CcSEcCtD
Glipizide—Confusional state—Naltrexone—alcohol dependence	0.00124	0.00365	CcSEcCtD
Glipizide—Anorexia—Acamprosate—alcohol dependence	0.00124	0.00365	CcSEcCtD
Glipizide—Oedema—Naltrexone—alcohol dependence	0.00123	0.00362	CcSEcCtD
Glipizide—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.00123	0.0109	CbGpPWpGaD
Glipizide—Shock—Naltrexone—alcohol dependence	0.00121	0.00357	CcSEcCtD
Glipizide—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00121	0.0108	CbGpPWpGaD
Glipizide—Jaundice—Citalopram—alcohol dependence	0.00119	0.00351	CcSEcCtD
Glipizide—Hyperhidrosis—Naltrexone—alcohol dependence	0.00119	0.0035	CcSEcCtD
Glipizide—Conjunctivitis—Citalopram—alcohol dependence	0.00119	0.0035	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00119	0.00349	CcSEcCtD
Glipizide—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00118	0.0105	CbGpPWpGaD
Glipizide—Insomnia—Acamprosate—alcohol dependence	0.00118	0.00346	CcSEcCtD
Glipizide—PPARG—brain—alcohol dependence	0.00118	0.0156	CbGeAlD
Glipizide—Anorexia—Naltrexone—alcohol dependence	0.00117	0.00345	CcSEcCtD
Glipizide—Sweating—Citalopram—alcohol dependence	0.00117	0.00345	CcSEcCtD
Glipizide—Paraesthesia—Acamprosate—alcohol dependence	0.00117	0.00344	CcSEcCtD
Glipizide—CYP2C9—digestive system—alcohol dependence	0.00117	0.0155	CbGeAlD
Glipizide—Dyspnoea—Acamprosate—alcohol dependence	0.00116	0.00342	CcSEcCtD
Glipizide—Somnolence—Acamprosate—alcohol dependence	0.00116	0.00341	CcSEcCtD
Glipizide—Hepatobiliary disease—Citalopram—alcohol dependence	0.00116	0.00341	CcSEcCtD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00116	0.0103	CbGpPWpGaD
Glipizide—Dyspepsia—Acamprosate—alcohol dependence	0.00115	0.00337	CcSEcCtD
Glipizide—ABCC8—Neuronal System—GABRB1—alcohol dependence	0.00114	0.0102	CbGpPWpGaD
Glipizide—Agranulocytosis—Citalopram—alcohol dependence	0.00114	0.00336	CcSEcCtD
Glipizide—Decreased appetite—Acamprosate—alcohol dependence	0.00113	0.00333	CcSEcCtD
Glipizide—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00112	0.00331	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00112	0.0033	CcSEcCtD
Glipizide—Insomnia—Naltrexone—alcohol dependence	0.00111	0.00328	CcSEcCtD
Glipizide—Constipation—Acamprosate—alcohol dependence	0.00111	0.00328	CcSEcCtD
Glipizide—Pain—Acamprosate—alcohol dependence	0.00111	0.00328	CcSEcCtD
Glipizide—CYP2C9—blood—alcohol dependence	0.00111	0.0148	CbGeAlD
Glipizide—KCNJ11—Neuronal System—GABRB1—alcohol dependence	0.00111	0.00987	CbGpPWpGaD
Glipizide—Paraesthesia—Naltrexone—alcohol dependence	0.00111	0.00325	CcSEcCtD
Glipizide—Rhinitis—Citalopram—alcohol dependence	0.0011	0.00324	CcSEcCtD
Glipizide—Hepatitis—Citalopram—alcohol dependence	0.0011	0.00323	CcSEcCtD
Glipizide—Dyspnoea—Naltrexone—alcohol dependence	0.0011	0.00323	CcSEcCtD
Glipizide—Somnolence—Naltrexone—alcohol dependence	0.0011	0.00322	CcSEcCtD
Glipizide—Hypoaesthesia—Citalopram—alcohol dependence	0.00109	0.00322	CcSEcCtD
Glipizide—Pharyngitis—Citalopram—alcohol dependence	0.00109	0.00321	CcSEcCtD
Glipizide—Feeling abnormal—Acamprosate—alcohol dependence	0.00107	0.00316	CcSEcCtD
Glipizide—Decreased appetite—Naltrexone—alcohol dependence	0.00107	0.00315	CcSEcCtD
Glipizide—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00106	0.00313	CcSEcCtD
Glipizide—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00106	0.00313	CcSEcCtD
Glipizide—Visual impairment—Citalopram—alcohol dependence	0.00106	0.00311	CcSEcCtD
Glipizide—Pain—Naltrexone—alcohol dependence	0.00105	0.0031	CcSEcCtD
Glipizide—Constipation—Naltrexone—alcohol dependence	0.00105	0.0031	CcSEcCtD
Glipizide—Urticaria—Acamprosate—alcohol dependence	0.00103	0.00304	CcSEcCtD
Glipizide—Abdominal pain—Acamprosate—alcohol dependence	0.00103	0.00303	CcSEcCtD
Glipizide—Eye disorder—Citalopram—alcohol dependence	0.00103	0.00302	CcSEcCtD
Glipizide—Flushing—Citalopram—alcohol dependence	0.00102	0.003	CcSEcCtD
Glipizide—Feeling abnormal—Naltrexone—alcohol dependence	0.00102	0.00299	CcSEcCtD
Glipizide—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00101	0.00296	CcSEcCtD
Glipizide—Chills—Citalopram—alcohol dependence	0.000986	0.0029	CcSEcCtD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000983	0.00876	CbGpPWpGaD
Glipizide—Arrhythmia—Citalopram—alcohol dependence	0.000981	0.00289	CcSEcCtD
Glipizide—Urticaria—Naltrexone—alcohol dependence	0.000979	0.00288	CcSEcCtD
Glipizide—Abdominal pain—Naltrexone—alcohol dependence	0.000974	0.00287	CcSEcCtD
Glipizide—ABCC8—Neuronal System—GABRA2—alcohol dependence	0.000972	0.00866	CbGpPWpGaD
Glipizide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000967	0.00862	CbGpPWpGaD
Glipizide—CYP2C9—endocrine gland—alcohol dependence	0.000964	0.0128	CbGeAlD
Glipizide—Hypersensitivity—Acamprosate—alcohol dependence	0.000959	0.00282	CcSEcCtD
Glipizide—Erythema—Citalopram—alcohol dependence	0.000956	0.00281	CcSEcCtD
Glipizide—Flatulence—Citalopram—alcohol dependence	0.000942	0.00277	CcSEcCtD
Glipizide—KCNJ11—Neuronal System—GABRA2—alcohol dependence	0.000942	0.0084	CbGpPWpGaD
Glipizide—Tension—Citalopram—alcohol dependence	0.000939	0.00276	CcSEcCtD
Glipizide—Asthenia—Acamprosate—alcohol dependence	0.000934	0.00275	CcSEcCtD
Glipizide—Nervousness—Citalopram—alcohol dependence	0.000929	0.00273	CcSEcCtD
Glipizide—Pruritus—Acamprosate—alcohol dependence	0.000921	0.00271	CcSEcCtD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00092	0.0082	CbGpPWpGaD
Glipizide—Muscle spasms—Citalopram—alcohol dependence	0.00092	0.00271	CcSEcCtD
Glipizide—Hypersensitivity—Naltrexone—alcohol dependence	0.000908	0.00267	CcSEcCtD
Glipizide—Vision blurred—Citalopram—alcohol dependence	0.000901	0.00265	CcSEcCtD
Glipizide—Tremor—Citalopram—alcohol dependence	0.000896	0.00264	CcSEcCtD
Glipizide—Diarrhoea—Acamprosate—alcohol dependence	0.000891	0.00262	CcSEcCtD
Glipizide—CYP3A4—digestive system—alcohol dependence	0.000889	0.0118	CbGeAlD
Glipizide—Ill-defined disorder—Citalopram—alcohol dependence	0.000887	0.00261	CcSEcCtD
Glipizide—Asthenia—Naltrexone—alcohol dependence	0.000884	0.0026	CcSEcCtD
Glipizide—Pruritus—Naltrexone—alcohol dependence	0.000872	0.00256	CcSEcCtD
Glipizide—CYP2C9—liver—alcohol dependence	0.000869	0.0115	CbGeAlD
Glipizide—Malaise—Citalopram—alcohol dependence	0.000862	0.00254	CcSEcCtD
Glipizide—Dizziness—Acamprosate—alcohol dependence	0.000861	0.00253	CcSEcCtD
Glipizide—Vertigo—Citalopram—alcohol dependence	0.000859	0.00253	CcSEcCtD
Glipizide—Syncope—Citalopram—alcohol dependence	0.000858	0.00252	CcSEcCtD
Glipizide—Leukopenia—Citalopram—alcohol dependence	0.000856	0.00252	CcSEcCtD
Glipizide—CYP3A4—blood—alcohol dependence	0.000847	0.0113	CbGeAlD
Glipizide—Diarrhoea—Naltrexone—alcohol dependence	0.000843	0.00248	CcSEcCtD
Glipizide—Loss of consciousness—Citalopram—alcohol dependence	0.000841	0.00247	CcSEcCtD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000836	0.00745	CbGpPWpGaD
Glipizide—Vomiting—Acamprosate—alcohol dependence	0.000828	0.00244	CcSEcCtD
Glipizide—Hypertension—Citalopram—alcohol dependence	0.000826	0.00243	CcSEcCtD
Glipizide—Rash—Acamprosate—alcohol dependence	0.000821	0.00242	CcSEcCtD
Glipizide—Dermatitis—Acamprosate—alcohol dependence	0.00082	0.00241	CcSEcCtD
Glipizide—Headache—Acamprosate—alcohol dependence	0.000816	0.0024	CcSEcCtD
Glipizide—Dizziness—Naltrexone—alcohol dependence	0.000815	0.0024	CcSEcCtD
Glipizide—Myalgia—Citalopram—alcohol dependence	0.000814	0.0024	CcSEcCtD
Glipizide—Arthralgia—Citalopram—alcohol dependence	0.000814	0.0024	CcSEcCtD
Glipizide—Anxiety—Citalopram—alcohol dependence	0.000811	0.00239	CcSEcCtD
Glipizide—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000809	0.00721	CbGpPWpGaD
Glipizide—Discomfort—Citalopram—alcohol dependence	0.000804	0.00237	CcSEcCtD
Glipizide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000802	0.00715	CbGpPWpGaD
Glipizide—Confusional state—Citalopram—alcohol dependence	0.000787	0.00232	CcSEcCtD
Glipizide—Vomiting—Naltrexone—alcohol dependence	0.000783	0.0023	CcSEcCtD
Glipizide—Oedema—Citalopram—alcohol dependence	0.000781	0.0023	CcSEcCtD
Glipizide—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000778	0.00693	CbGpPWpGaD
Glipizide—Rash—Naltrexone—alcohol dependence	0.000777	0.00229	CcSEcCtD
Glipizide—Dermatitis—Naltrexone—alcohol dependence	0.000776	0.00228	CcSEcCtD
Glipizide—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000774	0.0069	CbGpPWpGaD
Glipizide—Nausea—Acamprosate—alcohol dependence	0.000773	0.00228	CcSEcCtD
Glipizide—Headache—Naltrexone—alcohol dependence	0.000772	0.00227	CcSEcCtD
Glipizide—Shock—Citalopram—alcohol dependence	0.000768	0.00226	CcSEcCtD
Glipizide—Thrombocytopenia—Citalopram—alcohol dependence	0.000764	0.00225	CcSEcCtD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000763	0.0068	CbGpPWpGaD
Glipizide—Hyperhidrosis—Citalopram—alcohol dependence	0.000755	0.00222	CcSEcCtD
Glipizide—Anorexia—Citalopram—alcohol dependence	0.000744	0.00219	CcSEcCtD
Glipizide—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000741	0.00661	CbGpPWpGaD
Glipizide—CYP3A4—endocrine gland—alcohol dependence	0.000735	0.00976	CbGeAlD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000733	0.00653	CbGpPWpGaD
Glipizide—Nausea—Naltrexone—alcohol dependence	0.000732	0.00215	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000711	0.00209	CcSEcCtD
Glipizide—ABCC8—Neuronal System—ALDH2—alcohol dependence	0.000706	0.00629	CbGpPWpGaD
Glipizide—Insomnia—Citalopram—alcohol dependence	0.000706	0.00208	CcSEcCtD
Glipizide—Paraesthesia—Citalopram—alcohol dependence	0.000701	0.00206	CcSEcCtD
Glipizide—Dyspnoea—Citalopram—alcohol dependence	0.000696	0.00205	CcSEcCtD
Glipizide—Somnolence—Citalopram—alcohol dependence	0.000694	0.00204	CcSEcCtD
Glipizide—CYP3A4—nervous system—alcohol dependence	0.000688	0.00914	CbGeAlD
Glipizide—Dyspepsia—Citalopram—alcohol dependence	0.000687	0.00202	CcSEcCtD
Glipizide—KCNJ11—Neuronal System—ALDH2—alcohol dependence	0.000685	0.0061	CbGpPWpGaD
Glipizide—Decreased appetite—Citalopram—alcohol dependence	0.000679	0.002	CcSEcCtD
Glipizide—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000674	0.00198	CcSEcCtD
Glipizide—Pain—Citalopram—alcohol dependence	0.000667	0.00196	CcSEcCtD
Glipizide—Constipation—Citalopram—alcohol dependence	0.000667	0.00196	CcSEcCtD
Glipizide—CYP3A4—liver—alcohol dependence	0.000663	0.0088	CbGeAlD
Glipizide—CYP3A4—central nervous system—alcohol dependence	0.000662	0.0088	CbGeAlD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000648	0.00578	CbGpPWpGaD
Glipizide—Feeling abnormal—Citalopram—alcohol dependence	0.000643	0.00189	CcSEcCtD
Glipizide—Gastrointestinal pain—Citalopram—alcohol dependence	0.000638	0.00188	CcSEcCtD
Glipizide—Urticaria—Citalopram—alcohol dependence	0.00062	0.00182	CcSEcCtD
Glipizide—PPARG—Circadian rythm related genes—CRH—alcohol dependence	0.000618	0.00551	CbGpPWpGaD
Glipizide—Abdominal pain—Citalopram—alcohol dependence	0.000617	0.00182	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000614	0.00548	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000614	0.00547	CbGpPWpGaD
Glipizide—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000611	0.00545	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000607	0.00541	CbGpPWpGaD
Glipizide—Hypersensitivity—Citalopram—alcohol dependence	0.000575	0.00169	CcSEcCtD
Glipizide—PPARG—Circadian rythm related genes—SLC6A4—alcohol dependence	0.000575	0.00512	CbGpPWpGaD
Glipizide—Asthenia—Citalopram—alcohol dependence	0.00056	0.00165	CcSEcCtD
Glipizide—ABCC8—Neuronal System—GRIN2B—alcohol dependence	0.000558	0.00497	CbGpPWpGaD
Glipizide—Pruritus—Citalopram—alcohol dependence	0.000552	0.00162	CcSEcCtD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000551	0.00491	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—SLC6A3—alcohol dependence	0.00055	0.0049	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—GRIN2B—alcohol dependence	0.000541	0.00482	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000541	0.00482	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—DRD4—alcohol dependence	0.000541	0.00482	CbGpPWpGaD
Glipizide—Diarrhoea—Citalopram—alcohol dependence	0.000534	0.00157	CcSEcCtD
Glipizide—KCNJ11—Neuronal System—SLC6A3—alcohol dependence	0.000533	0.00475	CbGpPWpGaD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000529	0.00472	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000522	0.00466	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000522	0.00465	CbGpPWpGaD
Glipizide—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.00052	0.00463	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000517	0.0046	CbGpPWpGaD
Glipizide—Dizziness—Citalopram—alcohol dependence	0.000516	0.00152	CcSEcCtD
Glipizide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000509	0.00454	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—HTR7—alcohol dependence	0.000504	0.00449	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—DRD2—alcohol dependence	0.000504	0.00449	CbGpPWpGaD
Glipizide—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000503	0.00448	CbGpPWpGaD
Glipizide—Vomiting—Citalopram—alcohol dependence	0.000496	0.00146	CcSEcCtD
Glipizide—Rash—Citalopram—alcohol dependence	0.000492	0.00145	CcSEcCtD
Glipizide—Dermatitis—Citalopram—alcohol dependence	0.000492	0.00145	CcSEcCtD
Glipizide—Headache—Citalopram—alcohol dependence	0.000489	0.00144	CcSEcCtD
Glipizide—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000489	0.00436	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000483	0.00431	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ADH6—alcohol dependence	0.00048	0.00428	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ADH6—alcohol dependence	0.000466	0.00415	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—MAOA—alcohol dependence	0.000464	0.00414	CbGpPWpGaD
Glipizide—Nausea—Citalopram—alcohol dependence	0.000464	0.00136	CcSEcCtD
Glipizide—PPARG—Regulation of retinoblastoma protein—EP300—alcohol dependence	0.000455	0.00406	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—MAOA—alcohol dependence	0.00045	0.00401	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000444	0.00396	CbGpPWpGaD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—EP300—alcohol dependence	0.000434	0.00387	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000426	0.00379	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—AVP—alcohol dependence	0.000424	0.00378	CbGpPWpGaD
Glipizide—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000415	0.0037	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000413	0.00368	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CCAR1—alcohol dependence	0.000412	0.00367	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000405	0.00361	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—alcohol dependence	0.000403	0.00359	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000401	0.00357	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ADH1A—alcohol dependence	0.000398	0.00355	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000389	0.00347	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ADH1A—alcohol dependence	0.000386	0.00344	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000344	0.00307	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADH6—alcohol dependence	0.000344	0.00307	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000341	0.00304	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00034	0.00303	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ADH4—alcohol dependence	0.000338	0.00302	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000336	0.00299	CbGpPWpGaD
Glipizide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000332	0.00295	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ADH4—alcohol dependence	0.000328	0.00292	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000323	0.00288	CbGpPWpGaD
Glipizide—PPARG—PPARA activates gene expression—EP300—alcohol dependence	0.000303	0.0027	CbGpPWpGaD
Glipizide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	0.000296	0.00264	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000296	0.00264	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000293	0.00261	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ADH7—alcohol dependence	0.000288	0.00256	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADH1A—alcohol dependence	0.000285	0.00254	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000281	0.0025	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ADH7—alcohol dependence	0.000279	0.00249	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GGT2—alcohol dependence	0.000276	0.00246	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000274	0.00245	CbGpPWpGaD
Glipizide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000273	0.00243	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000272	0.00243	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GGT2—alcohol dependence	0.000268	0.00238	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000257	0.00229	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—GRIN2B—alcohol dependence	0.000253	0.00226	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ADH1B—alcohol dependence	0.000252	0.00225	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ADH1B—alcohol dependence	0.000245	0.00218	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000245	0.00218	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADH4—alcohol dependence	0.000243	0.00216	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000224	0.002	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000221	0.00197	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000219	0.00195	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000216	0.00193	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000213	0.0019	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.00021	0.00187	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—MAOB—alcohol dependence	0.000209	0.00186	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADH7—alcohol dependence	0.000206	0.00184	CbGpPWpGaD
Glipizide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	0.000204	0.00182	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—MAOB—alcohol dependence	0.000203	0.00181	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000201	0.00179	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GGT2—alcohol dependence	0.000198	0.00176	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—EP300—alcohol dependence	0.000187	0.00167	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000181	0.00161	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADH1B—alcohol dependence	0.000181	0.00161	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.00018	0.00161	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.00018	0.0016	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALDH2—alcohol dependence	0.000178	0.00158	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALDH2—alcohol dependence	0.000172	0.00154	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GOT2—alcohol dependence	0.000151	0.00135	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MAOB—alcohol dependence	0.00015	0.00134	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GOT2—alcohol dependence	0.000147	0.00131	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000146	0.0013	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000145	0.00129	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000143	0.00127	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP2E1—alcohol dependence	0.000142	0.00127	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP2E1—alcohol dependence	0.000138	0.00123	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000133	0.00118	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GGT1—alcohol dependence	0.00013	0.00116	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GOT1—alcohol dependence	0.00013	0.00116	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALDH2—alcohol dependence	0.000127	0.00114	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADH6—alcohol dependence	0.000127	0.00113	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GOT1—alcohol dependence	0.000127	0.00113	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GGT1—alcohol dependence	0.000127	0.00113	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000123	0.00109	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000119	0.00106	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—POMC—alcohol dependence	0.000117	0.00105	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—MAOA—alcohol dependence	0.000117	0.00104	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—MAOA—alcohol dependence	0.000113	0.00101	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GOT2—alcohol dependence	0.000108	0.000965	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADH1A—alcohol dependence	0.000105	0.000936	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP2E1—alcohol dependence	0.000102	0.000908	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GOT1—alcohol dependence	9.35e-05	0.000833	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GGT1—alcohol dependence	9.35e-05	0.000833	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EP300—alcohol dependence	9.1e-05	0.000811	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADH4—alcohol dependence	8.93e-05	0.000796	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MAOA—alcohol dependence	8.38e-05	0.000747	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADH6—alcohol dependence	8.36e-05	0.000745	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	8.13e-05	0.000724	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—POMC—alcohol dependence	7.75e-05	0.000691	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.73e-05	0.000689	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—POMC—alcohol dependence	7.61e-05	0.000678	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADH7—alcohol dependence	7.6e-05	0.000677	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—POMC—alcohol dependence	7.38e-05	0.000658	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GGT2—alcohol dependence	7.28e-05	0.000649	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADH1A—alcohol dependence	6.93e-05	0.000617	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADH1B—alcohol dependence	6.66e-05	0.000593	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADH4—alcohol dependence	5.89e-05	0.000525	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MAOB—alcohol dependence	5.52e-05	0.000492	CbGpPWpGaD
Glipizide—PPARG—Metabolism—POMC—alcohol dependence	5.46e-05	0.000486	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—EP300—alcohol dependence	5.05e-05	0.00045	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADH7—alcohol dependence	5.01e-05	0.000446	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—EP300—alcohol dependence	4.9e-05	0.000436	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GGT2—alcohol dependence	4.8e-05	0.000428	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDH2—alcohol dependence	4.69e-05	0.000418	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.51e-05	0.000402	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADH1B—alcohol dependence	4.39e-05	0.000391	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GOT2—alcohol dependence	3.99e-05	0.000356	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2E1—alcohol dependence	3.75e-05	0.000334	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MAOB—alcohol dependence	3.64e-05	0.000324	CbGpPWpGaD
Glipizide—PPARG—Metabolism—EP300—alcohol dependence	3.62e-05	0.000323	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GGT1—alcohol dependence	3.44e-05	0.000307	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GOT1—alcohol dependence	3.44e-05	0.000307	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDH2—alcohol dependence	3.09e-05	0.000276	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MAOA—alcohol dependence	3.09e-05	0.000275	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.99e-05	0.000267	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GOT2—alcohol dependence	2.63e-05	0.000234	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.47e-05	0.00022	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GGT1—alcohol dependence	2.27e-05	0.000202	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GOT1—alcohol dependence	2.27e-05	0.000202	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MAOA—alcohol dependence	2.04e-05	0.000181	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—POMC—alcohol dependence	2.01e-05	0.000179	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—EP300—alcohol dependence	1.33e-05	0.000119	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—POMC—alcohol dependence	1.33e-05	0.000118	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—EP300—alcohol dependence	8.79e-06	7.83e-05	CbGpPWpGaD
